Methylated free-circulatingHPP1DNA is an early response marker in patients with metastatic colorectal cancer
出版年份 2017 全文链接
标题
Methylated free-circulatingHPP1DNA is an early response marker in patients with metastatic colorectal cancer
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF CANCER
Volume 140, Issue 9, Pages 2134-2144
出版商
Wiley
发表日期
2017-01-26
DOI
10.1002/ijc.30625
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer
- (2015) J. Tie et al. ANNALS OF ONCOLOGY
- Changes in circulating microRNA-126 during treatment with chemotherapy and bevacizumab predicts treatment response in patients with metastatic colorectal cancer
- (2015) T F Hansen et al. BRITISH JOURNAL OF CANCER
- Extended RAS analysis for anti-epidermal growth factor therapy in patients with metastatic colorectal cancer
- (2015) J. Randolph Hecht et al. CANCER TREATMENT REVIEWS
- Early tumour shrinkage (ETS) and depth of response (DpR) in the treatment of patients with metastatic colorectal cancer (mCRC)
- (2015) Volker Heinemann et al. EUROPEAN JOURNAL OF CANCER
- Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial
- (2015) Susanna Hegewisch-Becker et al. LANCET ONCOLOGY
- Circulating cell-free methylated DNA and lactate dehydrogenase release in colorectal cancer
- (2014) Alexander B Philipp et al. BMC CANCER
- A multimarker panel for circulating tumor cells detection predicts patient outcome and therapy response in metastatic colorectal cancer
- (2014) Jorge Barbazán et al. INTERNATIONAL JOURNAL OF CANCER
- Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapy
- (2013) J M Jürgensmeier et al. BRITISH JOURNAL OF CANCER
- Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
- (2013) Muhammed Murtaza et al. NATURE
- Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
- (2013) Sarah-Jane Dawson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Generation and characterization of Tmeff2 mutant mice
- (2012) Tian Rui Chen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- CEA and CA19.9 as Early Predictors of Progression in Advanced/Metastatic Colorectal Cancer Patients Receiving Oxaliplatin-Based Chemotherapy and Bevacizumab
- (2012) Roberto Petrioli et al. CANCER INVESTIGATION
- Prognostic role of methylated free circulating DNA in colorectal cancer
- (2012) Alexander B. Philipp et al. INTERNATIONAL JOURNAL OF CANCER
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Toward optimized front-line therapeutic strategies in patients with metastatic colorectal cancer--an expert review from the International Congress on Anti-Cancer Treatment (ICACT) 2009
- (2010) R. Adam et al. ANNALS OF ONCOLOGY
- Bevacizumab combined with chemotherapy for patients with advanced colorectal cancer: a systematic review
- (2009) S. Welch et al. ANNALS OF ONCOLOGY
- Methylation of helicase-like transcription factor in serum of patients with colorectal cancer is an independent predictor of disease recurrence
- (2009) Andreas Herbst et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now